Cargando…
Development of a Microfluidic Array to Study Drug Response in Breast Cancer
Luminal geometries are common structures in biology, which are challenging to mimic using conventional in vitro techniques based on the use of Petri dishes. In this context, microfluidic systems can mimic the lumen geometry, enabling a large variety of studies. However, most microfluidic models stil...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6930663/ https://www.ncbi.nlm.nih.gov/pubmed/31801265 http://dx.doi.org/10.3390/molecules24234385 |
_version_ | 1783482945117356032 |
---|---|
author | Virumbrales-Muñoz, María Livingston, Megan K. Farooqui, Mehtab Skala, Melissa C. Beebe, David J. Ayuso, Jose M. |
author_facet | Virumbrales-Muñoz, María Livingston, Megan K. Farooqui, Mehtab Skala, Melissa C. Beebe, David J. Ayuso, Jose M. |
author_sort | Virumbrales-Muñoz, María |
collection | PubMed |
description | Luminal geometries are common structures in biology, which are challenging to mimic using conventional in vitro techniques based on the use of Petri dishes. In this context, microfluidic systems can mimic the lumen geometry, enabling a large variety of studies. However, most microfluidic models still rely on polydimethylsiloxane (PDMS), a material that is not amenable for high-throughput fabrication and presents some limitations compared with other materials such as polystyrene. Thus, we have developed a microfluidic device array to generate multiple bio-relevant luminal structures utilizing polystyrene and micro-milling. This platform offers a scalable alternative to conventional microfluidic devices designed in PDMS. Additionally, the use of polystyrene has well described advantages, such as lower permeability to hydrophobic molecules compared with PDMS, while maintaining excellent viability and optical properties. Breast cancer cells cultured in the devices exhibited high cell viability similar to PDMS-based microdevices. Further, co-culture experiments with different breast cell types showed the potential of the model to study breast cancer invasion. Finally, we demonstrated the potential of the microfluidic array for drug screening, testing chemotherapy drugs and photodynamic therapy agents for breast cancer. |
format | Online Article Text |
id | pubmed-6930663 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-69306632019-12-26 Development of a Microfluidic Array to Study Drug Response in Breast Cancer Virumbrales-Muñoz, María Livingston, Megan K. Farooqui, Mehtab Skala, Melissa C. Beebe, David J. Ayuso, Jose M. Molecules Article Luminal geometries are common structures in biology, which are challenging to mimic using conventional in vitro techniques based on the use of Petri dishes. In this context, microfluidic systems can mimic the lumen geometry, enabling a large variety of studies. However, most microfluidic models still rely on polydimethylsiloxane (PDMS), a material that is not amenable for high-throughput fabrication and presents some limitations compared with other materials such as polystyrene. Thus, we have developed a microfluidic device array to generate multiple bio-relevant luminal structures utilizing polystyrene and micro-milling. This platform offers a scalable alternative to conventional microfluidic devices designed in PDMS. Additionally, the use of polystyrene has well described advantages, such as lower permeability to hydrophobic molecules compared with PDMS, while maintaining excellent viability and optical properties. Breast cancer cells cultured in the devices exhibited high cell viability similar to PDMS-based microdevices. Further, co-culture experiments with different breast cell types showed the potential of the model to study breast cancer invasion. Finally, we demonstrated the potential of the microfluidic array for drug screening, testing chemotherapy drugs and photodynamic therapy agents for breast cancer. MDPI 2019-11-30 /pmc/articles/PMC6930663/ /pubmed/31801265 http://dx.doi.org/10.3390/molecules24234385 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Virumbrales-Muñoz, María Livingston, Megan K. Farooqui, Mehtab Skala, Melissa C. Beebe, David J. Ayuso, Jose M. Development of a Microfluidic Array to Study Drug Response in Breast Cancer |
title | Development of a Microfluidic Array to Study Drug Response in Breast Cancer |
title_full | Development of a Microfluidic Array to Study Drug Response in Breast Cancer |
title_fullStr | Development of a Microfluidic Array to Study Drug Response in Breast Cancer |
title_full_unstemmed | Development of a Microfluidic Array to Study Drug Response in Breast Cancer |
title_short | Development of a Microfluidic Array to Study Drug Response in Breast Cancer |
title_sort | development of a microfluidic array to study drug response in breast cancer |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6930663/ https://www.ncbi.nlm.nih.gov/pubmed/31801265 http://dx.doi.org/10.3390/molecules24234385 |
work_keys_str_mv | AT virumbralesmunozmaria developmentofamicrofluidicarraytostudydrugresponseinbreastcancer AT livingstonmegank developmentofamicrofluidicarraytostudydrugresponseinbreastcancer AT farooquimehtab developmentofamicrofluidicarraytostudydrugresponseinbreastcancer AT skalamelissac developmentofamicrofluidicarraytostudydrugresponseinbreastcancer AT beebedavidj developmentofamicrofluidicarraytostudydrugresponseinbreastcancer AT ayusojosem developmentofamicrofluidicarraytostudydrugresponseinbreastcancer |